Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Upadacitinib 15mg modified-release tablets
1001030AEAAAAAA
|
Upadacitinib | Upadacitinib | Musculoskeletal and Joint Diseases | 5 |
|
Adalimumab 40mg/0.4ml inj pre-filled disposable devices
1001030S0AAADAD
|
Adalimumab | Adalimumab | Musculoskeletal and Joint Diseases | 4 |
|
Anakinra 100mg/0.67ml inj pre-filled syringes
1001030R0AAAAAA
|
Anakinra | Anakinra | Musculoskeletal and Joint Diseases | 4 |
|
Benepali 50mg/1ml solution for injection pre-filled pens
1001030D0BCABAE
|
Benepali | Etanercept | Musculoskeletal and Joint Diseases | 4 |
|
Fenactol Retard 100mg tablets
1001010C0CJADAF
|
Fenactol | Diclofenac sodium | Musculoskeletal and Joint Diseases | 4 |
|
Glucosamine hydrochloride 1.5g chewable tablets
1001050A0AAACAC
|
Glucosamine hydrochloride | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | 4 |
|
Humira 40mg/0.4ml solution for injection pre-filled pens
1001030S0BBADAD
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | 4 |
|
Ibuleve Pain Relief 5% Spray
1003020P0BCAJAD
|
Ibuleve | Ibuprofen | Musculoskeletal and Joint Diseases | 4 |
|
Ibuprofen 200mg/5ml oral suspension
1001010J0AABIBI
|
Ibuprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 4 |
|
Indometacin 5mg/5ml oral liquid
1001010K0AABABA
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 4 |
|
Methofill 7.5mg/0.15ml inj pre-filled syringes
1001030U0BGAKBE
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 4 |
|
Methotrexate 7.5mg/5ml oral liquid
1001030U0AAAIAI
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 4 |
|
Metoject 15mg/0.3ml inj pre-filled syringes
1001030U0BEAHBG
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 4 |
|
Motusol Max 12 Hour Pain Relief 2.32% gel
1003020AFBCACAB
|
Motusol | Diclofenac diethyl | Musculoskeletal and Joint Diseases | 4 |
|
Amifampridine 10mg tablets
100201000AAADAD
|
Generic compound preparation BNF 1002010 | Other neuromuscularar transmisson preparations | Musculoskeletal and Joint Diseases | 3 |
|
Baclofen 5mg/5ml oral suspension
1002020C0AAA1A1
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | 3 |
|
Deep Freeze spray
1003020Y0BDAAAB
|
Deep Freeze | Freeze sprays and gels | Musculoskeletal and Joint Diseases | 3 |
|
Dicloflex 50mg gastro-resistant tablets (Almus)
1001010C0BQAKAE
|
Dicloflex | Diclofenac sodium | Musculoskeletal and Joint Diseases | 3 |
|
Enbrel 50mg/1ml inj pre-filled MyClic pens
1001030D0BBAFAE
|
Enbrel | Etanercept | Musculoskeletal and Joint Diseases | 3 |
|
Ibuprofen sodium dihydrate 200mg tablets
1001010APAAAAAA
|
Ibuprofen sodium dihydrate | Ibuprofen sodium dihydrate | Musculoskeletal and Joint Diseases | 3 |
|
Ibuprofen sodium dihydrate 400mg tablets
1001010APAAABAB
|
Ibuprofen sodium dihydrate | Ibuprofen sodium dihydrate | Musculoskeletal and Joint Diseases | 3 |
|
Larafen CR 200mg capsules
1001010L0BHAAAJ
|
Larafen | Ketoprofen | Musculoskeletal and Joint Diseases | 3 |
|
Methotrexate 30mg/0.6ml inj pre-filled syringes
1001030U0AABJBJ
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 3 |
|
Metoject 17.5mg/0.35ml inj pre-filled syringes
1001030U0BEAMBL
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 3 |
|
Metoject 20mg/0.4ml inj pre-filled syringes
1001030U0BEAIBH
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 3 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.